123 related articles for article (PubMed ID: 37596798)
1. Impact of clinical and histopathological characteristics on the disease-free survival of stage I-II acral melanoma patients.
Borges de Barros Primo R; Brito Nobre A; Santos BN; Nunes LF; Fernandes R; Abrão Possik P; Santos Bernardes S
Int J Dermatol; 2023 Oct; 62(10):1281-1288. PubMed ID: 37596798
[TBL] [Abstract][Full Text] [Related]
2. Surgical resection margin for T3-T4 primary acral melanoma: a multicenter retrospective cohort study.
Sun W; Xu Y; Qu X; Jin Y; Wang C; Yan W; Chen Y
Arch Dermatol Res; 2023 Oct; 315(8):2305-2312. PubMed ID: 36988664
[TBL] [Abstract][Full Text] [Related]
3. [Clinical features and prognosis of cutaneous melanoma].
Tian Y; Li MW; Liu QK; Kang H
Zhonghua Zhong Liu Za Zhi; 2022 Oct; 44(10):1146-1154. PubMed ID: 36319462
[No Abstract] [Full Text] [Related]
4. [Survival analysis in patients with cutaneous malignant melanoma].
Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
[TBL] [Abstract][Full Text] [Related]
5. The current management and prognosis of acral lentiginous melanoma.
Wells KE; Reintgen DS; Cruse CW
Ann Plast Surg; 1992 Jan; 28(1):100-3. PubMed ID: 1642394
[TBL] [Abstract][Full Text] [Related]
6. Is the prognosis and course of acral melanoma related to site-specific clinicopathological features?
Paolino G; Bekkenk MW; Didona D; Eibenschutz L; Richetta AG; Cantisani C; Viti G; Carbone A; Buccini P; De Simone P; Ferrari A; Scali E; Calvieri S; Silipo V; Cigna E; Viti GP; Bottoni U
Eur Rev Med Pharmacol Sci; 2016 Mar; 20(5):842-8. PubMed ID: 27010139
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of ulceration varies across Breslow thicknesses and clinical stages in acral melanoma: a retrospective study.
Wei X; Wu D; Chen Y; Li H; Zhang R; Yao H; Chi Z; Cui C; Bai X; Mao L; Qi Z; Li K; Lan S; Chen L; Guo R; Yao X; Lian B; Kong Y; Dai J; Tang B; Wang X; Guo J; Si L
Br J Dermatol; 2022 Jun; 186(6):977-987. PubMed ID: 35042273
[TBL] [Abstract][Full Text] [Related]
8. Acral lentiginous melanoma histotype predicts outcome in clinical stage I-II melanoma patients: an International multicenter study.
Mandalà M; Rutkowski P; Galli F; Patuzzo R; De Giorgi V; Rulli E; Gianatti A; Valeri B; Merelli B; Szumera-Ciećkiewicz A; Massi D; Maurichi A; Teterycz P; Santinami M
ESMO Open; 2022 Jun; 7(3):100469. PubMed ID: 35421840
[TBL] [Abstract][Full Text] [Related]
9. Tumor infiltrating lymphocytes in acral lentiginous melanoma: a study of a large cohort of cases from Latin America.
Castaneda CA; Torres-Cabala C; Castillo M; Villegas V; Casavilca S; Cano L; Sanchez J; Dunstan J; Calderon G; De La Cruz M; Cotrina JM; Gomez HL; Galvez R; Abugattas J
Clin Transl Oncol; 2017 Dec; 19(12):1478-1488. PubMed ID: 28577153
[TBL] [Abstract][Full Text] [Related]
10. Acral lentiginous melanoma: histopathological prognostic features of 121 cases.
Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
Br J Dermatol; 2007 Aug; 157(2):311-8. PubMed ID: 17596173
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal study of prognostic factors for localized cutaneous melanoma in patients who have been disease-free for five years.
Bancalari B; Ferrer-Guillen S; Tejera-Vaquerizo A; Requena C; García-Casado Z; Traves V; Kumar R; Nagore E
Eur J Dermatol; 2021 Apr; 31(2):192-198. PubMed ID: 33875409
[TBL] [Abstract][Full Text] [Related]
12. Recurrence rate and survival implications of surgical margins in patients with acral melanoma. Is a wide margin necessary?
Lino-Silva LS; Hernández-Romero R; García-Herrera JS; Zepeda-Najar C; Salcedo-Hernández RA; León-Takahashi AM; Escobar-Jiménez MG; Herrera-Gómez Á
Gac Med Mex; 2023; 159(1):38-43. PubMed ID: 36930558
[TBL] [Abstract][Full Text] [Related]
13. Relationship between tumor-associated immune infiltrate and p16 staining over clinicopathological features in acral lentiginous melanoma.
Castaneda CA; Castillo M; Torres-Cabala C; Bernabe LA; Casavilca S; Villegas V; Sanchez J; de la Cruz M; Dunstan J; Cotrina JM; Gomez HL; Chavez C; Landa-Baella MP; Tello K; Felix BF; Abugattas J
Clin Transl Oncol; 2019 Sep; 21(9):1127-1134. PubMed ID: 30778854
[TBL] [Abstract][Full Text] [Related]
14. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
[TBL] [Abstract][Full Text] [Related]
15. Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: a study of 522 consecutive cases.
Chi Z; Li S; Sheng X; Si L; Cui C; Han M; Guo J
BMC Cancer; 2011 Feb; 11():85. PubMed ID: 21349197
[TBL] [Abstract][Full Text] [Related]
16. Different progression pattern between acral and nonacral melanoma: A retrospective, comparative, clinicoprognostic study of 492 cases of primary cutaneous melanoma according to tumor site.
Jung JM; Jung CJ; Won CH; Chang SE; Lee MW; Choi JH; Lee WJ
Indian J Dermatol Venereol Leprol; 2021 [SEASON]; 87(4):498-508. PubMed ID: 33871216
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in young women with cutaneous melanoma.
Burton AL; Egger ME; Quillo AR; Stromberg AJ; Hagendoorn L; Scoggins CR; Martin RC; McMasters KM; Callender GG
Am J Surg; 2014 Jan; 207(1):102-8. PubMed ID: 24330977
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Clinical and Histopathological Factors on Disease Progression and Survival in Thick Cutaneous Melanomas.
Țăpoi DA; Derewicz D; Gheorghișan-Gălățeanu AA; Dumitru AV; Ciongariu AM; Costache M
Biomedicines; 2023 Sep; 11(10):. PubMed ID: 37892990
[TBL] [Abstract][Full Text] [Related]
19. Appraisal of clinicopathological prognosticators in advanced acral lentiginous melanoma with characterization of PD-L1 and CD8/CD4 immunoprofiles.
Chuang IC; Jang CS
Jpn J Clin Oncol; 2022 Sep; 52(9):975-981. PubMed ID: 35662346
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Volumetric Parameters Measured by Pretreatment 18F FDG PET/CT in Patients With Cutaneous Malignant Melanoma.
Son SH; Kang SM; Jeong SY; Lee SW; Lee SJ; Lee J; Ahn BC
Clin Nucl Med; 2016 Jun; 41(6):e266-73. PubMed ID: 27055144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
